Navigation Links
Endologix Announces Favorable Markman Ruling in Cook Patent Litigation
Date:8/17/2011

IRVINE, Calif., Aug. 17, 2011 /PRNewswire/ -- Endologix, Inc. (Nasdaq: ELGX), developer and marketer of minimally invasive treatments for aortic disorders, announced today that Judge Tanya Walton Pratt of the United States District Court for the Southern District of Indiana in Indianapolis has issued a Markman ruling in the ongoing patent infringement lawsuit filed against the Company by Cook Medical.

In a Markman ruling, the court determines the meaning of disputed patent claim terms at issue in patent litigation.  After a briefing and oral argument on April 15, 2011 as to the meaning of a number of terms of the claims of the two patents that Cook is asserting in the lawsuit, Judge Pratt adopted many of Endologix's proposed constructions for several terms of claims of both asserted patents, including constructions that the Company considers to be important for the outcome of the case.

The trial date for the patent infringement lawsuit has not yet been set but is expected to be set for fall 2012.

John McDermott, President and Chief Executive Officer of Endologix, commented, "We are pleased with the results of the Markman hearing, remain confident in our position going forward and intend to continue to pursue our numerous defenses."

About Endologix, Inc.Endologix, Inc. develops and manufactures minimally invasive treatments for aortic disorders. The Company's focus is endovascular stent grafts for the treatment of abdominal aortic aneurysms (AAA). AAA is a weakening of the wall of the aorta, the largest artery in the body, resulting in a balloon-like enlargement. Once AAA develops, it continues to enlarge and, if left untreated, becomes increasingly susceptible to rupture. The overall patient mortality rate for ruptured AAA is approximately 75%, making it a leading cause of death in the U.S. Additional information can be found on Endologix's Web site at www.endologix.com.

Forward-Looking Statements Except for historical information contained herein, this news release contains forward-looking statements relating to the continuing litigation with Cook Medical.   The achievement of the plans and objectives in such statements involves risks and uncertainties including, but not limited to, risks and uncertainties related to the costs and outcome of intellectual property litigation, many of which are difficult or impossible to predict accurately and many of which are beyond the control of Endologix. The Company undertakes no obligation to update its forward looking statements. Please refer to the Company's Annual Report on Form 10-K for the year ended December 31, 2010, and the Company's other filings with the Securities and Exchange Commission, for more detailed information regarding these risks and other factors that may cause actual results to differ materially from those expressed or implied.COMPANY CONTACT:

INVESTOR CONTACTS:Endologix, Inc.

The Ruth GroupJohn McDermott, CEO

Nick Laudico (646) 536-7030(949) 595-7200

Zack Kubow (646) 536-7020www.endologix.com
'/>"/>

SOURCE Endologix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Endologix Announces First U.S. Implant of AFX™ Endovascular AAA System
2. Endologix to Present at Two Upcoming Conferences
3. Endologix Reports 22% Second Quarter 2011 Revenue Growth
4. Endologix and LeMaitre Vascular Enter Early Termination Agreement for European Distribution Rights of Endologix Products
5. Endologix to Report Second Quarter 2011 Financial Results on July 21, 2011
6. Endologix Announces FDA Approval of AFX™ Endovascular AAA System
7. Endologix to Present at the 2011 Bank of America Merrill Lynch Health Care Conference
8. Endologix Files Form 10-K; Nellix Purchase Price Allocation Finalized
9. Endologix to Present at the ROTH 23rd Annual OC Growth Stock Conference
10. Endologix Reports 41% Fourth Quarter 2010 Revenue Growth
11. Endologix Announces Presentation of Favorable Initial PEVAR Trial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2017)... The Rebound mobile app is poised to become a vital ... prescription drug addiction. The app empowers users to develop an ... their dosage in a safe, controlled manner while maximizing well-being. ... 100,000 people to sign up will enjoy 3 months of ... ...
(Date:9/27/2017)... NEW YORK , Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), ... solutions, today announced that its MyDario product is expected to appear on ... for when The Dr. Oz Show airs in your area: http://www.doctoroz.com/page/where-watch-dr-oz-show ... The nine-time Emmy award-winning, The Dr. ... ...
(Date:9/22/2017)... , Sept. 22, 2017  As the latest Obamacare ... Bill Cassidy (R-LA) and Lindsey Graham ... that the medical device industry is in an odd ... tax, the 2.3% excise tax on medical device sales ... also want covered patients, increased visits and hospital customers ...
Breaking Medicine Technology:
(Date:10/12/2017)... ... October 12, 2017 , ... ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 ... characterized by frequent cessation in breathing. Oral appliances can offer significant relief to ...
(Date:10/12/2017)... ... 12, 2017 , ... The company has developed a suite ... regulatory authorities worldwide. From Children’s to Adults 50+, every formula has been developed ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, ...
(Date:10/12/2017)... ... ... The American College of Medical Informatics (ACMI) will present the 2017 Morris ... of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium is taking ... in the field of medical informatics, this prestigious award is presented to an individual ...
(Date:10/12/2017)... Maryland (PRWEB) , ... October 12, 2017 , ... ... magnetic drug delivery system that we intend to develop to enable prevention of ... can lead to severe hearing loss, especially in pediatric patients. For cisplatin, hearing ...
(Date:10/12/2017)... Malvern, PA (PRWEB) , ... October 12, 2017 , ... ... is the recipient of a 2017 Folio Magazine Eddie Digital Award for ‘Best ... New York City on October 11, 2017. , The annual award competition recognizes editorial ...
Breaking Medicine News(10 mins):